Guardant Health
GH
#1787
Rank
โ‚น1.046 T
Marketcap
โ‚น7,980
Share price
-3.96%
Change (1 day)
115.85%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น289.89

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น312.16. In 2024 the company made an earnings per share (EPS) of -โ‚น335.74 an increase over its 2023 EPS that were of -โ‚น403.64.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น289.89-13.66%
2024-โ‚น335.74-16.82%
2023-โ‚น403.64-33.12%
2022-โ‚น603.5860%
2021-โ‚น377.2455.04%
2020-โ‚น243.32207.14%
2019-โ‚น79.22-19.81%
2018-โ‚น98.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น261.90-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น201.82-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA